Hoffmann-La Roche regulatory update

Hoffmann-La Roche Syntex, a member of the Roche group, submitted a supplemental NDA to the FDA requesting approval of oral Cytovene (ganciclovir) for the prevention of cytomegalovirus disease in HIV-...